Modification of purinergic signaling in the hippocampus of streptozotocin-induced diabetic rats

Neuroscience

Volumn 149, Issue 2, 2007, Pages 382-391

  Duarte, J M N ^a   Oses, J P ^a   Rodrigues, R J ^a   Cunha, R A ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

ATP; diabetes; ecto nucleotidases; hippocampus; P2 receptors; streptozotocin

Indexed keywords

ADENOSINE TRIPHOSPHATE; PURINE P2 RECEPTOR; PURINE RECEPTOR;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATABOLISM; CEREBROSPINAL FLUID; CONTROLLED STUDY; EVOKED RESPONSE; HIPPOCAMPUS; HOMEOSTASIS; LEARNING; MALE; MEMORY; NERVE CELL PLASTICITY; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES; WESTERN BLOTTING;

ADENOSINE TRIPHOSPHATE; ANIMALS; BLOTTING, WESTERN; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EXTRACELLULAR SPACE; HIPPOCAMPUS; HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; MALE; NERVE ENDINGS; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION;

EID: 35348895686     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.08.005     Document Type: Article

References (53)

1. Abbracchio M.P., Burnstock G., Boeynaems J.M., Barnard E.A., Boyer J.L., Kennedy C., Knight G.E., Fumagalli M., Gachet C., Jacobson K.A., and Weisman G.A. International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58 (2006) 281-341
2. Abbracchio M.P., and Verderio C. Pathophysiological roles of P2 receptors in glial cells. Novartis Found Symp 276 (2006) 91-103
3. 2 receptor. Brain Res 952 (2002) 31-37
4. 2A receptor activation and facilitation of long-term potentiation in rat hippocampal slices. Neuroscience 122 (2003) 111-121
5. Biessels G.J., Kamal A., Ramakers G.M., Urban I.J., Spruijt B.M., Erkelens D.W., and Gispen W.H. Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats. Diabetes 45 (1996) 1259-1266
6. Buxton D.B., Robertson S.M., and Olson M.S. Stimulation of glycogenolysis by adenine nucleotides in the perfused rat liver. Biochem J 237 (1986) 773-780
7. Cavaliere F., D'Ambrosi N., Ciotti M.T., Mancino G., Sancesario G., Bernardi G., and Volonté C. Glucose deprivation and chemical hypoxia: neuroprotection by P2 receptor antagonists. Neurochem Int 38 (2001) 189-197
8. Cavaliere F., D'Ambrosi N., Sancesario G., Bernardi G., and Volonte C. Hypoglycaemia-induced cell death: features of neuroprotection by the P2 receptor antagonist basilen blue. Neurochem Int 38 (2001) 199-207
9. Convit A., Wolf O.T., Tarshish C., and de Leon M.J. Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly. Proc Natl Acad Sci U S A 100 (2003) 2019-2022
10. Coutinho-Silva R., Parsons M., Robson T., Lincoln J., and Burnstock G. P2X and P2Y purinoceptor expression in pancreas from streptozotocin-diabetic rats. Mol Cell Endocrinol 204 (2003) 141-154
11. Cox D.J., Kovatchev B.P., Gonder-Frederick L.A., Summers K.H., McCall A., Grimm K.J., and Clarke W.L. Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes. Diabetes Care 28 (2005) 71-77
12. Cunha R.A. Regulation of the ecto-nucleotidase pathway in rat hippocampal nerve terminals. Neurochem Res 26 (2001) 979-991
13. Cunha R.A., and Ribeiro J.A. ATP as a presynaptic modulator. Life Sci 68 (2000) 119-137
14. 1 receptors. J Neurosci 18 (1998) 1987-1995
15. Cunha R.A., Vizi E.S., Ribeiro J.A., and Sebastião A.M. Preferential release of ATP and its extracellular catabolism as a source of adenosine upon high- but not low-frequency stimulation of rat hippocampal slices. J Neurochem 67 (1996) 2180-2187
16. di Virgilio F. Dr. Jekyll/Mr. Hyde: the dual role of extracellular ATP. J Auton Nerv Syst 81 (2000) 59-63
17. 2A receptor density in the hippocampus of streptozotocin-induced diabetic rats. Neurochem Int 48 (2006) 144-150
18. 1 receptor density in the hippocampus of streptozotocin-induced diabetic rats. Exp Neurol 204 (2007) 479-484
19. 7 receptor: a candidate susceptibility gene for NOD diabetes. Diabetes 53 (2004) 2012-2017
20. Fields R.D., and Burnstock G. Purinergic signalling in neuron-glia interactions. Nat Rev Neurosci 7 (2006) 423-436
21. Fischer Y., Becker C., and Löken C. Purinergic inhibition of glucose transport in cardiomyocytes. J Biol Chem 274 (1999) 755-761
22. Franke H., Krugel U., and Illes P. P2 receptors and neuronal injury. Pflugers Arch 452 (2006) 622-644
23. Gispen W.H., and Biessels G.J. Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci 23 (2000) 542-549
24. Guyot L.L., Diaz F.G., O'Regan M.H., Song D., and Phillis J.W. The effect of streptozotocin-induced diabetes on the release of excitotoxic and other amino acids from the ischemic rat cerebral cortex. Neurosurgery 48 (2001) 385-390
25. Haussinger D., Stehle T., and Gerok W. Actions of extracellular UTP and ATP in perfused rat liver. A comparative study. Eur J Biochem 167 (1987) 65-71
26. Jones T.W., and Davis E.A. Hypoglycemia in children with type 1 diabetes: current issues and controversies. Pediatr Diabetes 4 (2003) 143-150
27. 3H]purine outflow evoked by short-term hypoxia and hypoglycemia in rat hippocampal slices. Brain Res 823 (1999) 183-190
28. Khakh B.S., and North R.A. P2X receptors as cell-surface ATP sensors in health and disease. Nature 442 (2006) 527-532
29. 12 skeletal muscle cells. Arch Biochem Biophys 401 (2002) 205-214
30. Kloda A., Clements J.D., Lewis R.J., and Adams D.J. Adenosine triphosphate acts as both a competitive antagonist and a positive allosteric modulator at recombinant N-methyl-D-aspartate receptors. Mol Pharmacol 65 (2004) 1386-1396
31. Lammer A., Gunther A., Beck A., Krugel U., Kittner H., Schneider D., Illes P., and Franke H. Neuroprotective effects of the P2 receptor antagonist PPADS on focal cerebral ischaemia-induced injury in rats. Eur J Neurosci 23 (2006) 2824-2828
32. 1 receptor is involved in the maintenance of glucose homeostasis and in insulin secretion in mice. Purinergic Signal 1 (2005) 145-151
33. Lester-Coll N., Rivera E.J., Soscia S.J., Doiron K., Wands J.R., and de la Monte S.M. Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease. J Alzheimers Dis 9 (2006) 13-33
34. Lynch M.A. Long-term potentiation and memory. Physiol Rev 84 (2004) 87-136
35. McCorry D., Nicolson A., Smith D., Marson A., Feltbower R.G., and Chadwick D.W. An association between type 1 diabetes and idiopathic generalized epilepsy. Ann Neurol 59 (2006) 204-206
36. Neary J.T., and Kang Y. Signaling from P2 nucleotide receptors to protein kinase cascades induced by CNS injury: implications for reactive gliosis and neurodegeneration. Mol Neurobiol 31 (2005) 95-103
37. North R.A., and Verkhratsky A. Purinergic transmission in the central nervous system. Pflugers Arch 452 (2006) 479-485
38. Ortinau S., Laube B., and Zimmermann H. ATP inhibits NMDA receptors after heterologous expression and in cultured hippocampal neurons and attenuates NMDA-mediated neurotoxicity. J Neurosci 23 (2003) 4996-5003
39. Pankratov Y.V., Lalo U.V., and Krishtal O.A. Role for P2X receptors in long-term potentiation. J Neurosci 22 (2002) 8363-8369
40. Pellerin L., and Magistretti P.J. Neuroenergetics: calling upon astrocytes to satisfy hungry neurons. Neuroscientist 10 (2004) 53-62
41. Pitkänen A., and Sutula T.P. Is epilepsy a progressive disorder?. Prospects for new therapeutic approaches in temporal-lobe epilepsy. Lancet Neurol 1 (2002) 173-181
42. Rees D.A., and Alcolado J.C. Animal models of diabetes mellitus. Diabet Med 22 (2005) 359-370
43. 4 receptors in the rat hippocampus. J Neurosci 25 (2005) 6286-6295
44. Rusakov D.A., Harrison E., and Stewart M.G. Synapses in the hippocampus occupy only 1-2% of cell membranes and are spaced less than half-micron apart: a quantitative ultrastructural analysis with discussion of physiological implications. Neuropharmacology 37 (1998) 513-521
45. Saravia F.E., Revsin Y., Gonzalez Deniselle M.C., Gonzalez S.L., Roig P., Lima A., Homo-Delarche F., and De Nicola A.F. Increased astrocyte reactivity in the hippocampus of murine models of type 1 diabetes: the nonobese diabetic (NOD) and streptozotocin-treated mice. Brain Res 957 (2002) 345-353
46. 1 receptors. Glia 49 (2005) 288-300
47. 7 activity in human fibroblasts from diabetic patients: a possible pathogenetic mechanism for vascular damage in diabetes. Arterioscler Thromb Vasc Biol 24 (2004) 1240-1245
48. Solini A., Chiozzi P., Morelli A., Passaro A., Fellin R., and di Virgilio F. Defective P2Y purinergic receptor function: a possible novel mechanism for impaired glucose transport. J Cell Physiol 197 (2003) 435-444
49. Squire L.R., Stark C.E., and Clark R.E. The medial temporal lobe. Annu Rev Neurosci 27 (2004) 279-306
50. 7-induced pore formation and apoptosis: an early effect of diabetes on the retinal microvasculature. Invest Ophthalmol Vis Sci 45 (2004) 1026-1032
51. Trudeau F., Gagnon S., and Massicotte G. Hippocampal synaptic plasticity and glutamate receptor regulation: influences of diabetes mellitus. Eur J Pharmacol 490 (2004) 177-186
52. Yamato T., Misumi Y., Yamasaki S., Kino M., and Aomine M. Diabetes mellitus decreases hippocampal release of neurotransmitters: an in vivo microdialysis study of awake, freely moving rats. Diabetes Nutr Metab 17 (2004) 128-136
53. Zimmermann H. Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch Pharmacol 362 (2000) 299-309